FDA Enables Generic Insulins with Lower Prices
Insulin Nation
MARCH 26, 2020
Sanofi, NovoNordisk, and Lilly have created huge and profitable businesses by filing hundreds of patents for every type of insulin in order to prevent generics from being legally possible. acknowledges that today’s patent laws around biologic drugs like insulin have resulted in little competition in the marketplace and more expensive drugs.
Let's personalize your content